McKesson Corporation (MCK)
Health Care · Healthcare pharmaceutical and medical-surgical distribution
McKesson is a healthcare services giant that orchestrates the entire pharmaceutical and medical supply chain—from drug distribution and specialty oncology care to technology platforms that connect patients, pharmacies, and providers.
What McKesson Corporation does
McKesson is a diversified healthcare services leader that distributes branded, generic, specialty, and biosimilar pharmaceutical drugs alongside medical-surgical supplies across North America. The company operates four main segments: North American Pharmaceutical (drug distribution and pharmacy solutions), Oncology & Multispecialty (specialty drug distribution, oncology networks, cell/gene therapy services), Prescription Technology Solutions (electronic prior authorization, prescription pricing, patient enrollment platforms), and Medical-Surgical Solutions (medical supplies to ambulatory and extended care settings). The company partners with biopharma companies, care providers, pharmacies, manufacturers, and governments to improve care accessibility and affordability.
Themes: ["pharmaceutical distribution","specialty pharma & oncology","healthcare technology platforms","patient medication access","supply chain logistics","prescription pricing transparency","healthcare provider networks","cell and gene therapy","prescription adherence","healthcare cost containment"]
Fundamentals
- Price$792.81 as of 2026-07-09 close
- Market cap$92.8B as of 2026-07-10
- 1-year return+9.0% as of 2026-07-09 close
- P/E19.48 as of 2026-07-10
- Net margin+1.2% as of 2026-07-10
- Gross margin+3.6% as of 2026-07-10
- ROE+39.4% as of 2026-07-10
- Debt / equity1.29 as of 2026-07-10
- Revenue growth (YoY)+12.4% as of 2026-07-10
- Revenue CAGR (3y)+13.4% SEC XBRL
- Beta0.33 as of 2026-07-10
Dividend: yield +0.4%; 5-year non-decreasing per-share dividend streak (SEC XBRL).
Key risks (from latest filing)
["Regulatory and pricing pressure: Government regulation and price transparency requirements impact drug distribution margins and reimbursement rates","Supply chain disruption: Dependence on complex logistics and inventory management across multiple therapeutic categories and temperature-controlled distribution channels","Segment separation execution: Company plans to separate Medical-Surgical Solutions into independent company, creating organizational and operational risks"]
Competitors & peers
- Cardinal Health (CAH)
- AmerisourceBergen (ABC)
- Hy-Vee
- Amazon Pharmacy
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.